Agree with you. That's why I have a significant position in this stock, and plan on holding it for a long time
The other big positive for me is that it has long-term headwinds. Spending on pathology services is only going to grow in the future as the population ages and technology advances.
There are significant economies of scale and barriers to entry that benefit SHL. As long as it is managed half-decently, without any disasters or scandals, revenue and profits should be able to grow consistently for a long time.
Next Update Pending, page-2
-
- There are more pages in this discussion • 62 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SHL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$27.94 |
Change
0.210(0.76%) |
Mkt cap ! $13.36B | |||
| Open | High | Low | Value | Volume |
| $27.79 | $27.99 | $27.68 | $19.32M | 693.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2492 | $27.89 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $27.96 | 3198 | 2 |
View Market Depth
| Last trade - 16.10pm 15/08/2024 (20 minute delay) ? |
| SHL (ASX) Chart |